Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Circulation|June 3, 2004
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonistsMichel Azizi, Joël Ménard
Journal of Hypertension|April 13, 2004
Renin-angiotensin system blockade: to what extent?Joël Ménard, Michel Azizi
Journal of Hypertension|September 1, 2007
The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskirenJoël Ménard, Michel Azizi
Cardiovascular Drugs and Therapy|March 7, 2012
Renin inhibitors and cardiovascular and renal protection: an endless quest?Michel Azizi, Joël Ménard
Diagnostic and Interventional Imaging|May 23, 2012
Renal denervation and treatment-resistant hypertension: a matter of importance for interventional radiologyMarc Sapoval, Michel Azizi
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 11, 2010
Review: measurement of plasma renin: a critical review of methodologyMichel Azizi, Joel Menard
Seminars in Nephrology|September 18, 2007
Rationale for combining blockers of the renin-angiotensin systemMichel Azizi, Grégoire Wuerzner
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Renin inhibition with aliskirenGrégoire Wuerzner, Michel Azizi
Presse Medicale (Paris, France : 1983)|November 17, 2019
[Secondary hypertension in women]Laurence Amar, Michel Azizi
Circulation|August 14, 2025
A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsMichel Azizi, Stephen P Juraschek
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Circulation|June 3, 2004
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonistsMichel Azizi, Joël Ménard
Journal of Hypertension|April 13, 2004
Renin-angiotensin system blockade: to what extent?Joël Ménard, Michel Azizi
Journal of Hypertension|September 1, 2007
The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskirenJoël Ménard, Michel Azizi
Cardiovascular Drugs and Therapy|March 7, 2012
Renin inhibitors and cardiovascular and renal protection: an endless quest?Michel Azizi, Joël Ménard
Diagnostic and Interventional Imaging|May 23, 2012
Renal denervation and treatment-resistant hypertension: a matter of importance for interventional radiologyMarc Sapoval, Michel Azizi
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 11, 2010
Review: measurement of plasma renin: a critical review of methodologyMichel Azizi, Joel Menard
Seminars in Nephrology|September 18, 2007
Rationale for combining blockers of the renin-angiotensin systemMichel Azizi, Grégoire Wuerzner
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Renin inhibition with aliskirenGrégoire Wuerzner, Michel Azizi
Presse Medicale (Paris, France : 1983)|November 17, 2019
[Secondary hypertension in women]Laurence Amar, Michel Azizi
Circulation|August 14, 2025
A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsMichel Azizi, Stephen P Juraschek
Pageof 27